I agree mj is here to say... in fact, its real sustainable growth stage is just now emerging out of a long consolidation process. everything to this point has been hiccup, removal and fill as the industry has had to arrange its chairs, set up and deal w/ regs, allow the big boys to estbl positions w/ the players or themselves they see as the bastions of this new inudstry.
now w/ covid evaporating & the riots quelling, its clear neither biden nor trump will get in the way of this emerging industry train, at least in regards to full 50 state med. furthermore, covid gave investors one last chance to load up in the basement of the various entities shaping the industry.
ogi, crlbf & cron seem like the best shots from a buy price & risk reward. however, I think your trashing trtc too much. sure it got to this point on printed up shares, but unlike so many small players from 4 years back, its not only still standing. it has actual viable products & niche. what makes you think that as we enter '21 & the real growth rollout starts in the industry, trtc wont be able to not only take advantage of investor interest, but finally be able to put sustained growing revs & earnings on the table?
News 
Market Data 
Discover 
